EGFR and glioblastoma: EGFRvIII: The epidermal growth factor receptor (EGFR) deletion mutation, EGFRvIII, is expressed in about ~33% of GBM and promotes tumorigenesis through various mechanisms [15,16,17,18,19,20,21,22,23].